Your session is about to expire
← Back to Search
SRP-3D for Pain Management
Study Summary
This trial will test if a new drug is effective and safe. Half the participants will receive the drug and half will receive a placebo. The trial is double-blind, meaning neither the participants nor the researchers will know who is receiving the drug or the placebo.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Are individuals of age 65 and below accepted in this research endeavor?
"To qualify for this trial, patients must be between the age of 18 and 55. There are 71 studies available to individuals younger than 18 and 247 options for those over 65 years old."
Has the FDA sanctioned SRP-3D (diethylamide) for clinical use?
"The safety of SRP-3D (diethylamide) is assessed as a 1 on the scale from 1 to 3 due to it being in Phase 1 trials. This indicates that there are only limited data available which attest to its efficacy and security."
Can I enroll in this trial?
"This clinical trial is seeking 56 individuals, ranging from 18 to 55 years of age and suffering from physical pain. Eligible participants must be male or female; however, females are prohibited from being pregnant or nursing. Furthermore, BMI should fall between 18-32 kg/m2 for inclusion in the study. Additionally, proficiency in either English or Spanish is required as well as agreement with associated testing procedures and confinement periods throughout the research period. Moreover, good health criteria must be met alongside appropriate vital signs at screening visits while non-childbearing potential women have to use contraception methods and men need to demonstrate surgical sterility - if not then they too"
Are there still openings available for this clinical experiment?
"According to the clinicaltrials.gov database, this trial is open for recruitment and began on January 13th 2023. The most recent update was posted on August 3rd 2022."
How many participants are partaking in this study?
"Indeed, according to the details on clinicaltrials.gov, recruitment for this trial is ongoing. This research project was initially published on January 13th 2023 and amended most recently in August 3rd 2022. The investigators are looking to enrol 56 patients from a single medical centre."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Average response time
- < 1 Day
Typically responds via
Most responsive sites:
- Quotient Sciences-Miami, Inc.: < 24 hours
Share this study with friends
Copy Link
Messenger